Venlo, the Netherlands, Oct. 04, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay.
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the ...
RIDE-001, a first-in-class nanomedicine, effectively trained myeloid progenitor cells to elicit myeloid-driven anticancer innate immune responses, as demonstrated in preclinical studies across multipl ...
RA patients on upadacitinib and methotrexate showed robust antibody and T-cell responses to the recombinant zoster vaccine over 60 weeks. The vaccine maintained a satisfactory humoral response in 71.4 ...
As the first and only PD-L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition ...
A fluorescence image of a tertiary lymphoid structure (TLS), the lymph node-like immune structure developed in tumors. B cells (white) are making a dense aggregate of TLS. High endothelial venules ...
The Brighterside of News on MSN
New antibody restores immune system to fight pancreatic cancer
Survival rarely comes easy when pancreatic ductal adenocarcinoma strikes. Most people learn of it only after it has spread, ...
MS and MOGAD share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback